A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus.
Authors:
Open Access
- 1 November 1990
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 172 (5) , 1391-1401
Abstract
This report describes a murine amniotic fluid (MAF) immunosuppressive factor that has properties similar to transforming growth factor beta (TGF-beta). The MAF factor exhibits TGF-beta-like activity in stimulating soft agar colony formation by AKR-2B cells and inhibiting thymidine uptake by Mv1Lu cells. We demonstrate that both the immunosuppressive and TGF-beta-like activities of the MAF factor are completely neutralized by anti-TGF-beta 2-specific antibodies and not by anti-TGF-beta 1-specific antisera. The immunosuppressive factor in MAF is novel in that it appears to be identical or very closely related to TGF-beta 2 and is active in its native state. This active and anti-TGF-beta 2-neutralizable factor chromatographs at approximately 70 kD on Sephadex at neutral pH and appears to be able to complex with alpha-fetoprotein in native amniotic fluid. Chromatography of native MAF under acidic conditions demonstrates a lower molecular mass protein that chromatographs on BioGel in the same position as the mature 25-kD TGF-beta. This protein has the biological properties of TGF-beta and is immunosuppressive. Both of these activities are neutralizable with anti-TGF-beta 2 but not with anti-TGF-beta 1 or other antisera. By Northern analysis, we find high levels of TGF-beta 2 mRNA (with little or no TGF-beta 1) in the pregnant uterus that peak around day 15 of gestation and then fall rapidly by day 19 as birth approaches. The TGF-beta 2-like factor could possibly play a role in maternal immunity, in the retention of the fetal allograft, as well as in regulating fetal and neonatal immunological competence.Keywords
This publication has 58 references indexed in Scilit:
- Isolation and characterization of a distinct immunoregulatory isoform of alpha-fetoprotein produced by the normal fetus.Journal of Experimental Medicine, 1989
- Inflammatory and immunomodulatory roles of TGF-βImmunology Today, 1989
- PROLONGATION OF MALE SKIN GRAFT SURVIVAL IN FEMALE MICE TREATED WITH AMNIOTIC FLUIDTransplantation, 1988
- Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.Journal of Experimental Medicine, 1987
- The transforming growth factor-β system, a complex pattern of cross-reactive ligands and receptorsCell, 1987
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.Journal of Experimental Medicine, 1986
- Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in cultureJournal of Cellular Physiology, 1982
- Suppressive factors in amniotic fluid and newborn serum: Is α-fetoprorein involved?Cellular Immunology, 1978
- Immunosuppressive Factors in Mouse Amniotic Fluid and Neonate SerumImmunological Communications, 1978
- Immunosuppressive Activity of Mouse Amniotic FluidImmunological Communications, 1974